# OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

> **NCT02736175** · PHASE3 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 438 (actual)

## Conditions studied

- Post-Surgical Ocular Pain
- Post-Surgical Ocular Inflammation

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Placebo Vehicle

## Key facts

- **NCT ID:** NCT02736175
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 438 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736175, "OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02736175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*